Organic sodium salts
Apexbio Technology LLC NBQX disodium salt 479347-86-9 50mg
NBQX disodium salt (CAS 479347-86-9) is a selective competitive antagonist of -amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors a subtype of ionotropic glutamate receptors By inhibiting AMPA receptor-mediated excitatory neurotransmission NBQX disodium salt is utilized to study synaptic plasticity and excitotoxicity mechanisms This compound has been shown to exhibit neuroprotective and anticonvulsant properties in preclinical models and is widely used in research on neurological disorders such as Alzheimer s disease epilepsy and schizophrenia to elucidate the physiological and pathological roles of AMPA receptor signaling
Apexbio Technology LLC NBQX disodium salt 479347-86-9 10mg
NBQX disodium salt (CAS 479347-86-9) is a selective competitive antagonist of -amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors a subtype of ionotropic glutamate receptors By inhibiting AMPA receptor-mediated excitatory neurotransmission NBQX disodium salt is utilized to study synaptic plasticity and excitotoxicity mechanisms This compound has been shown to exhibit neuroprotective and anticonvulsant properties in preclinical models and is widely used in research on neurological disorders such as Alzheimer s disease epilepsy and schizophrenia to elucidate the physiological and pathological roles of AMPA receptor signaling
Medchemexpress LLC NBQX disodium | 479347-86-9 | C12H6N4Na2O6S | 5 MG
NBQX disodium is a highly selective and competitive AMPA receptor antagonist. It exhibits neuroprotective and anticonvulsant activity by targeting AMPA and kainate binding sites, with minimal affinity for the glutamate recognition site on the NMDA receptor complex. It has demonstrated efficacy in decreasing PTZ-induced seizures and neuroprotection in focal ischemia models.
- Highly selective and competitive AMPA receptor antagonist
- Exhibits neuroprotective activity
- Shows anticonvulsant activity
- High affinity for AMPA and kainate binding sites
- Minimal affinity for the glutamate recognition site on the NMDA receptor complex
- Decreases seizures induced by PTZ
- Neuroprotective in focal ischemia models
Medchemexpress LLC NBQX disodium | 479347-86-9 | C12H6N4Na2O6S | 1 ML
NBQX disodium is a highly selective and competitive AMPA receptor antagonist, known for its neuroprotective and anticonvulsant activities. It displays high affinity for AMPA and kainate binding sites.
- Highly selective and competitive AMPA receptor antagonist
- Exhibits neuroprotective activity
- Demonstrates anticonvulsant activity
- Targets AMPA receptors
- Decreases seizures induced by PTZ in animal models
- Neuroprotective in focal ischaemia models
Apexbio Technology LLC NBQX disodium salt 479347-86-9 100mg
NBQX disodium salt (CAS 479347-86-9) is a selective competitive antagonist of -amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors a subtype of ionotropic glutamate receptors By inhibiting AMPA receptor-mediated excitatory neurotransmission NBQX disodium salt is utilized to study synaptic plasticity and excitotoxicity mechanisms This compound has been shown to exhibit neuroprotective and anticonvulsant properties in preclinical models and is widely used in research on neurological disorders such as Alzheimer s disease epilepsy and schizophrenia to elucidate the physiological and pathological roles of AMPA receptor signaling
Medchemexpress LLC NBQX disodium | 479347-86-9 | C12H6N4Na2O6S | 50 MG
NBQX disodium (FG9202 disodium) is a highly selective and competitive AMPA receptor antagonist. It exhibits neuroprotective and anticonvulsant activity. This product shows high affinity for AMPA and kainate binding sites, with minimal or no affinity for the glutamate recognition site on the NMDA receptor complex. It has also demonstrated neuroprotective effects in a focal ischaemia model in rats.
- Highly selective and competitive AMPA receptor antagonist
- Possesses neuroprotective activity
- Exhibits anticonvulsant activity
- High affinity for AMPA and kainate binding sites
- Minimal affinity for the glutamate recognition site on the NMDA receptor complex
Medchemexpress LLC NBQX (disodium) | 479347-86-9 | MFCD00220677 | C12H6N4Na2O6S | 100 MG
NBQX disodium (FG9202 disodium) is a highly selective and competitive AMPA receptor antagonist, known for its neuroprotective and anticonvulsant activities. This compound demonstrates a high affinity for AMPA and kainate binding sites, while showing minimal affinity for the glutamate recognition site on the NMDA receptor complex. Research indicates its effectiveness in protecting against focal ischaemia and reducing seizures in experimental models.
- Highly selective and competitive AMPA receptor antagonist
- Exhibits neuroprotective properties
- Shows anticonvulsant efficacy
- Possesses high affinity for AMPA and kainate binding sites
- Low affinity for NMDA receptor complex
Medchemexpress LLC Benzo[f]quinoxaline-7-sulfonamide, 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-, sodium salt (1:2) | 479347-86-9 | C12H6N4Na2O6S | 25 MG
NBQX disodium is a highly selective and competitive antagonist of the AMPA receptor, exhibiting neuroprotective and anticonvulsant activity. It possesses a high affinity for AMPA and kainate binding sites, with minimal affinity for the glutamate recognition site on the NMDA receptor complex.
- Highly selective and competitive AMPA receptor antagonist
- Exhibits neuroprotective activity
- Shows anticonvulsant activity
- High affinity for AMPA and kainate binding sites
- Little to no affinity for the NMDA receptor complex